about
Diphenyleneiodonium inhibits NF-kappaB activation and iNOS expression induced by IL-1beta: involvement of reactive oxygen speciesResveratrol modulates cytokine-induced Jak/STAT activation more efficiently than 5-aminosalicylic acid: an in vitro approachDexamethasone-induced and estradiol-induced CREB activation and annexin 1 expression in CCRF-CEM lymphoblastic cells: evidence for the involvement of cAMP and p38 MAPKPhysiology and pathophysiology of musculoskeletal aging: current research trends and future priorities.Expression and function of K(ATP) channels in normal and osteoarthritic human chondrocytes: possible role in glucose sensingImpaired glucose transporter-1 degradation and increased glucose transport and oxidative stress in response to high glucose in chondrocytes from osteoarthritic versus normal human cartilage.Diacerhein and rhein prevent interleukin-1beta-induced nuclear factor-kappaB activation by inhibiting the degradation of inhibitor kappaB-alpha.Assessment of cell line competence for studies of pharmacological GPR30 modulation.Differential effects of the essential oils of Lavandula luisieri and Eryngium duriaei subsp. juresianum in cell models of two chronic inflammatory diseases.Screening of five essential oils for identification of potential inhibitors of IL-1-induced Nf-kappaB activation and NO production in human chondrocytes: characterization of the inhibitory activity of alpha-pinene.Dexamethasone prevents interleukin-1beta-induced nuclear factor-kappaB activation by upregulating IkappaB-alpha synthesis, in lymphoblastic cells.Evaluation of the anti-inflammatory, anti-catabolic and pro-anabolic effects of E-caryophyllene, myrcene and limonene in a cell model of osteoarthritis.Nitric oxide synthase isoforms and NF-kappaB activity in normal and osteoarthritic human chondrocytes: regulation by inducible nitric oxide.Expression and function of the insulin receptor in normal and osteoarthritic human chondrocytes: modulation of anabolic gene expression, glucose transport and GLUT-1 content by insulin.Assessment of strategies to increase chondrocyte viability in cryopreserved human osteochondral allografts: evaluation of the glycosylated hydroquinone, arbutin.Regulation of catecholamine release and tyrosine hydroxylase in human adrenal chromaffin cells by interleukin-1beta: role of neuropeptide Y and nitric oxide.Differential roles of hydrogen peroxide and superoxide in mediating IL-1-induced NF-kappa B activation and iNOS expression in bovine articular chondrocytes.Insulin decreases autophagy and leads to cartilage degradation.Anti-inflammatory and chondroprotective activity of (+)-α-pinene: structural and enantiomeric selectivity.Editorial: The Physiology of Inflammation-The Final Common Pathway to DiseaseChanges in the subcellular distribution of the rat uterus oestrogen receptor as induced by oestradiol, tamoxifen and ZD 182,780Hydrogen peroxide mediates interleukin-1beta-induced AP-1 activation in articular chondrocytes: implications for the regulation of iNOS expressionRole of glucose as a modulator of anabolic and catabolic gene expression in normal and osteoarthritic human chondrocytesDiabetes-accelerated experimental osteoarthritis is prevented by autophagy activationDichotomous Sirtuins: Implications for Drug Discovery in Neurodegenerative and Cardiometabolic DiseasesThe importance of determining circadian parameters in pharmacological studiesExpression and function of the nonclassical estrogen receptor, GPR30, in human cartilage and chondrocytes
P50
Q28360546-466599BF-733D-47EC-AF39-5D674A1B4DFFQ28543472-855BAC7C-EC7A-4A2A-9875-7E7718B0287BQ35609390-628B8E93-D92D-4E46-B2AF-B80E2384B9F2Q36750428-25E1C253-50E1-4B70-961B-87F4AE6E4225Q37076937-9518E037-F963-4367-8791-4C3063E0B31FQ37270809-B41C9A17-4C3C-43D6-8668-24A8180250FFQ38363570-85B4F5B6-6D01-42BF-8AE8-26A1C8B239EFQ38758796-F6EC3681-FC4E-42C8-A9E8-D0159E2C7FE1Q38917468-8DF3F913-45D4-4C91-9236-6255E0044A17Q39796280-EE287E56-FA06-45AC-B2FB-9E10313E78EAQ40648086-C3304A45-26B8-431D-B1F9-3508DE3924B4Q41524566-541DD2A2-F43E-48C4-99D6-CB67500CCB92Q42439720-CB73E084-D0A4-4958-8F0C-42C96509FA60Q42484035-FED0CD63-E973-4FDD-A3E9-ADB1318AFDABQ43276985-002AD41E-EF07-4F97-B95D-FC66C3679BA5Q43872629-A0367B17-4960-4BD3-B300-CC2E3B72DBA5Q44309205-D8C294D2-80E7-4D1D-8575-F4C3E6EF851BQ54235231-AF24C9CE-33C1-4750-88A9-71F59EC3A740Q54382605-6EA05FE6-BA65-43A7-8C22-DFA8C88460F3Q60046996-D2C227A9-2065-4522-B1AF-3462AE5AAA96Q71338328-2F9B465D-4BCF-430C-B5D3-99E325E14027Q75195023-5E6A1DF1-7409-46D5-9F08-7B495580F508Q84184623-ACF33392-0058-41D0-8547-C9DD4CA5A18FQ87845924-33B79774-6D4A-4DF0-A71A-2BC3613A547BQ91194672-4CE53DC9-87BC-473B-9DCD-187BA0781FB2Q92103324-6634830F-2E17-49DA-8454-8B4F2AFCFDBDQ93176687-778A1AB0-C698-4D94-A518-89E12D17C19E
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Alexandrina F. Mendes
@ast
Alexandrina F. Mendes
@en
Alexandrina F. Mendes
@es
Alexandrina F. Mendes
@nl
Alexandrina F. Mendes
@sl
type
label
Alexandrina F. Mendes
@ast
Alexandrina F. Mendes
@en
Alexandrina F. Mendes
@es
Alexandrina F. Mendes
@nl
Alexandrina F. Mendes
@sl
altLabel
Ferreira-Mendes A. Alexandrina F. Mendes, Alexandrina Ferreira Mendes
@en
prefLabel
Alexandrina F. Mendes
@ast
Alexandrina F. Mendes
@en
Alexandrina F. Mendes
@es
Alexandrina F. Mendes
@nl
Alexandrina F. Mendes
@sl
P1053
B-4833-2014
P106
P1153
7102443487
P21
P2798
P31
P3829
P3835
alexandrina-ferreira-mendes
P496
0000-0001-5511-7132